v3.26.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Product Information [Line Items]          
Accumulated deficit $ 13,526,169   $ 13,526,169   $ 13,612,268
Cash equivalents 0   0   0
Uncertain tax position $ 0   $ 0   $ 0
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer [Member]          
Product Information [Line Items]          
Concentration risk, percentage 100.00% 100.00% 100.00% 100.00%  
Accounts Receivable [Member] | Customer Concentration Risk [Member] | One Customer [Member]          
Product Information [Line Items]          
Concentration risk, percentage     100.00%    
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Two Customer [Member]          
Product Information [Line Items]          
Concentration risk, percentage         100.00%
Polomar Specialty Pharmacy LLC [Member]          
Product Information [Line Items]          
Minority interest percentage 100.00%   100.00%